News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
September, 2024
September 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Does the blast percentage in NPM1m mutated myeloid malignancies matter?
Jun 27, 2024, 19:08

Does the blast percentage in NPM1m mutated myeloid malignancies matter?

Anand Patel, Assistant Professor and Director of the Inpatient Leukemia Service at the University of Chicago, shared on X:

“Does the blast percentage in NPM1m mutated myeloid malignancies matter? Some publications supporting that the disease behaves like AML even when blasts < 20%.”.

Anand Patel

Read further.
Source: Anand Patel/X

Anand Patel cancer myeloid malignancies OncoDaily Oncology
Special Coverage
Blog
Sep 5, 2024, 00:05
September is Gynecologic Cancer Awareness Month - NRG Oncology
Blog
Sep 5, 2024, 00:05
The International Myeloma Foundation has helped bring over 17 treatments for multiple myeloma to market
Blog
Sep 5, 2024, 00:02
Submit your clinical trials - ESTRO
Blog
Sep 5, 2024, 00:01
NCI's Rare Tumor Clinics bring pediatric patients and families with researchers and physicians to learn more, provide treatment recommendations, and accelerate progress
Blog
Sep 5, 2024, 00:01
Inequitable access to vaccines and high-performance screening tools accounts for the highest rates of new cases and deaths due to cervical cancer in the African region
Blog
Sep 5, 2024, 00:01
IARC is highlighting research areas scientists are working in to mark Childhood Cancer Awareness Month
Blog
Sep 4, 2024, 23:56
Honoring Gina Lee, Assistant Professor at UCI
Blog
Sep 4, 2024, 23:51
A life should be long - Children's Cancer Institute
Blog
Sep 4, 2024, 23:03
New episodes of the N.U.R.T.U.R.E. Podcast Series, presented by EONS, are now available
Blog
Sep 4, 2024, 18:10
Kashyap Patel: Our third annual gala to underscore the significance of collaboration in cancer care
Insight
Sep 4, 2024, 18:04
Darolutamide, enzalutamide, and apalutamide in Non-metastatic Castration-Resistant Prostate Cancer
Blog
Sep 4, 2024, 17:52
Ryan Fitzpatrick: The 6th annual MPN MDS EU Focus meeting by MD Education